Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy

Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka

Clin Mol Hepatol. 2023;29(4):851-868. Published online March 9, 2023

DOI: https://doi.org/10.3350/cmh.2022.0434

View: 6675 Download: 352 Web of Science: 6 Crossref: 9

Original Article

Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients

Xiaoning Wu, Xiaoqian Xu, Jialing Zhou, Yameng Sun, Huiguo Ding, Wen Xie, Guofeng Chen, Anlin Ma, HongXin Piao, Bingqiong Wang, Shuyan Chen, Tongtong Meng, Xiaojuan Ou, Hwai-I Yang, Jidong Jia, Yuanyuan Kong, Hong You

Clin Mol Hepatol. 2023;29(3):747-762. Published online May 10, 2023

DOI: https://doi.org/10.3350/cmh.2023.0121

View: 2256 Download: 128

Editorial

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?

Young-Suk Lim

Clin Mol Hepatol. 2023;29(1):118-119. Published online November 29, 2022

DOI: https://doi.org/10.3350/cmh.2022.0413

View: 2919 Download: 158 Web of Science: 2 Crossref: 2

Review

RNA interference as a novel treatment strategy for chronic hepatitis B infection

Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen

Clin Mol Hepatol. 2022;28(3):408-424. Published online February 17, 2022

DOI: https://doi.org/10.3350/cmh.2022.0012

View: 7760 Download: 610 Web of Science: 28 Crossref: 33

Editorial

Elimination of hepatitis C: What would be the practical approach?

Hyung Joon Yim

Clin Mol Hepatol. 2021;27(1):97-99. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0304

View: 4965 Download: 116 Web of Science: 2 Crossref: 2

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease

Sen Han, Ting Zhang, Praveen Kusumanchi, Nazmul Huda, Yanchao Jiang, Zhihong Yang, Suthat Liangpunsakul

Clin Mol Hepatol. 2020;26(4):705-714. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0166

View: 4384 Download: 89 Web of Science: 8 Crossref: 9

Editorial

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion

Jin Wook Chung

Clin Mol Hepatol. 2018;24(2):135-136. Published online February 22, 2018

DOI: https://doi.org/10.3350/cmh.2018.1001

View: 7085 Download: 151

Review

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

Edward Wolfgang Lee, Sarah Khan

Clin Mol Hepatol. 2017;23(4):265-272. Published online November 8, 2017

DOI: https://doi.org/10.3350/cmh.2017.0111

View: 10934 Download: 359 Web of Science: 38 Crossref: 34

Original Article

Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection

Yoo-Kyung Cho, Young Nam Kim, Byung-Cheol Song

Clin Mol Hepatol. 2014;20(4):368-375. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.368

View: 8025 Download: 60 Web of Science: 11 Crossref: 10

Multiplex polymerase chain reaction test for the diagnosis of acute viral hepatitis A

Nae-Yun Heo, Young-Suk Lim, Jihyun An, Sun-Young Ko, Heung-Bum Oh

Clin Mol Hepatol. 2012;18(4):397-403. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.397

View: 7346 Download: 52 Crossref: 1

Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines

Sung Hoon Choi, Hye Won Shin, Jun Yong Park, Ji Young Yoo, Do Young Kim, Weon Sang Ro, Chae-Ok Yun, Kwang-Hyub Han

Clin Mol Hepatol. 2010;16(3):280-287. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.280

View: 8544 Download: 63 Crossref: 11

3

The value of serum retinol-binding protein 4 Levels for determining disease severity in patients with chronic Liver disease

Jung Hyun Kwon, M.D., Seong Tae Park Gi Dae Kim, Ph.D. Chan Ran You, M.D., Jin Dong Kim, M.D., Hyun Young Woo, M.D., Jeong Won Jang, M.D. Chang Wook Kim, M.D., Si Hyun Bae, M.D., Jong Young Choi, M.D., Seung Kew Yoon, M.D.

Clin Mol Hepatol. 2009;15(1):59-69. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.59

View: 4870 Download: 60 Crossref: 9

Inhibition of in vitro hepatitis B virus replication by Lentivirus-mediated short-hairpin RNA against HBx

Jin Wook Kim , Sang Hyub Lee , Young Soo Park , Sook Hyang Jeong , Na Young Kim , Dong Ho Lee

Clin Mol Hepatol. 2009;15(1):15-24. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.15

View: 4903 Download: 57 Crossref: 6

1

Inhibition of hepatitis B virus replication by RNA interference

Yun Gyu Park

Clin Mol Hepatol. 2009;15(1):1-6. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.1

View: 4214 Download: 32

3

Clinical Significance of Intrahepatic HCV RNA Level in Chronic HCV Infection

Jae Young Jang, M.D., Yun Soo Kim, M.D. Sang Gyune Kim, M.D., Young Seok Kim, M.D., Young Deok Cho, M.D., Joon Sung Lee, M.D., So Young Jin, M.D. Moon Sung Lee, M.D., Ju Hyun Kim, M.D. Chan Sup Shim, M.D., and Boo Sung Kim, M.D.

Clin Mol Hepatol. 2006;12(4):515-523. Published online January 1, 1970

View: 2438 Download: 22

13

Taehan Kan Hakhoe Chi (The Korean Journal of Hepatology) and Index Medicus (Medline/PubMed)

Dong Hoo Lee

Clin Mol Hepatol. 2003;9(1):35-41. Published online January 1, 2000

View: 3118 Download: 13

3

Quantitation of Hepatitis C Virus RNA by Competitive RT-PCR and DNA-ELISA Method

Kang Seok Seo, M.D., Seung Jung Kee M.D., Soon Pal Suh M.D., Sei Jong Kim, M.D.

Clin Mol Hepatol. 2000;6(2):156-171. Published online January 1, 2000

View: 2102 Download: 26

Prevalence of Hepatitis G Virus Infection in Patients with Chronic Renal Failure

Woo-Won Shin, M.D., Kyung-Ha Song, M.D., Jeong-Hwan Cho, M.D., Hyun-Sook Ahn＊, Sung-Wook Lee, M.D., Dong-Joo Keum, M.D., Sung-Jin Bae, M.D.†, Sun-Taec Kim, M.D.†, Kwang-Yul Chang, M.D., Jung-Ha Park, M.D., Myung-Hwan Noh, M.D., Seong-Eun Kim, M.D., Sang-Young Han, M.D., Seok-Reyol Choi, M.D., and Ki-Hyun Kim, M.D.

Clin Mol Hepatol. 2000;6(1):82-90. Published online January 1, 2000

View: 2500 Download: 16

The Detection of Hepatitis G Virus RNA by RT - PCR in Various Liver Diseases

Kwang Hyub Han , Won Choi , Young Nyun Park , Young Woong Hwang , Wang Sik Ryu , Eun Sin Park , Kwan Sik Lee , Chae Yoon Chon , Young Myoung Moon , Chan Il Park

Clin Mol Hepatol. 1997;3(2):123-132.

View: 2486 Download: 21

Factors Predictive of Response to Interferon Therapy in Chronic HCV Infection

Yun Soo Kim , So Young Kwan , Dong Jin Suh , Chang Hong Lee

Clin Mol Hepatol. 1996;2(2):176-185.

View: 19202 Download: 14

1 |

Viewed By 5142	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5003	MAFLD: How is it different from NAFLD?
Viewed By 4912	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3637	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3578	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search